ISPO

antisense strategies

Ribozyme strategies in cancer therapeutics

T Ohnuma MD PhD, F Wang MD, M Halatsch MD, JF Holland MD

The role of TGF-beta in mediating the effects of bFGF in human breast cancer cells

J Nordenberg PhD, Y Kanfi MSc , R Wieder MD PhD , E Beery MSc , T Livnat PhD , J Yahalom MD , E Fenig MD

Tumor growth inhibition and cell cycle effects of antisense oligodeoxynucleotides targeting human thymidylate synthase

RW Berg PhD , E Behrend PhD , M Werner , PJ Ferguson PhD , C Postenka BSc , M Vincent MD , J Koropatnick PhD

Novel center-modified antisense oligonucleotides: therapeutic efficacy, pharmacology, and toxicology

R Zhang MD PhD DABT, H Wang MD PhD

Antisense anti-MDM2 oligonucleotide therapeutics as a new approach to human cancer therapy: in vitro and in vivo studies

H Wang MD PhD, R Zhang MD PhD DABT